Most Read Articles
Pearl Toh, 6 months ago
Concomitant statin therapy was associated with an attenuation of tocilizumab (TCZ)-mediated increase in serum lipids in patients with rheumatoid arthritis (RA), according to a recent post hoc analysis of randomized clinical studies.
Jairia Dela Cruz, 5 months ago
Patients with early rheumatoid arthritis (RA) may benefit from the initial addition of certolizumab pegol (CZP) to optimized methotrexate (MTX) therapy, as this strategy potentially prevents joint destruction, according to the results of the phase III C-OPERA* study.
2 months ago
The addition of prednisone to methotrexate (MTX)-based treat-to-target strategy for early rheumatoid arthritis (RA) leads to a lower initiation rate of a first biological disease-modifying antirheumatic drug and a significant improvement in radiographic outcomes, a study has shown. Furthermore, prednisone use does not increase the incidence of long-term glucocorticoid-related comorbidities.
Jairia Dela Cruz, 5 months ago
Fidaxomicin shows potential for treating Clostridium difficile infection (CDI), with response and recurrence being significantly better in patients with a first CDI episode than in those with prior episodes, according to data from an open-label study.

Axial spondyloarthritis

one year ago
In this series, professor Joachim Sieper talks about the impact of axial spondyloarthritis and the importance of early detection.
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 months ago
Concomitant statin therapy was associated with an attenuation of tocilizumab (TCZ)-mediated increase in serum lipids in patients with rheumatoid arthritis (RA), according to a recent post hoc analysis of randomized clinical studies.
Jairia Dela Cruz, 5 months ago
Patients with early rheumatoid arthritis (RA) may benefit from the initial addition of certolizumab pegol (CZP) to optimized methotrexate (MTX) therapy, as this strategy potentially prevents joint destruction, according to the results of the phase III C-OPERA* study.
2 months ago
The addition of prednisone to methotrexate (MTX)-based treat-to-target strategy for early rheumatoid arthritis (RA) leads to a lower initiation rate of a first biological disease-modifying antirheumatic drug and a significant improvement in radiographic outcomes, a study has shown. Furthermore, prednisone use does not increase the incidence of long-term glucocorticoid-related comorbidities.
Jairia Dela Cruz, 5 months ago
Fidaxomicin shows potential for treating Clostridium difficile infection (CDI), with response and recurrence being significantly better in patients with a first CDI episode than in those with prior episodes, according to data from an open-label study.